pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
BIDIL
BIDIL (HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE)
AZURITY
0
catalysts
Phase 1
BIIB-142
Lupus Nephritis
$BIIB
BIOGEN INC.
0
catalysts
Phase 2
BIO-106
Solid Tumor
BiOneCure Therapeutics Inc
0
catalysts
Preclinical
BIOS: GM I
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Sylamore Bio
← prev
page 63 of 231
next →
131
Pain
89
Neurology
1
0
catalysts
Preclinical
BIOS:MPS I
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Sylamore Bio
0
catalysts
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE)
LABS JUVISE
0
catalysts
Phase 1
BJ-001
Solid Tumor
BJ Bioscience Inc
0
catalysts
Phase 1
BJ-005
Solid Tumor
BJ Bioscience Inc
0
catalysts
Phase 2
BLB-101
Coronavirus Disease 2019 (COVID-19)
Blue Lake Biotechnology Inc
0
catalysts
Phase 2
BLB-201
Respiratory Syncytial Virus (RSV) Infections
Blue Lake Biotechnology Inc
0
catalysts
Phase 1
BLM-11D1
Refractory Acute Myeloid Leukemia
Sichuan Biokin Pharmaceutical Co Ltd
0
catalysts
Phase 1
BLM-14D1
Gastrointestinal Tumor
Sichuan Biokin Pharmaceutical Co Ltd
0
catalysts
Phase 1
BLM-17D1
Endometrial Cancer
Sichuan Biokin Pharmaceutical Co Ltd
0
catalysts
Phase 2
BLU-808
Chronic Inducible Urticaria
Blueprint Medicines Corp
0
catalysts
BLUDIGO
BLUDIGO (INDIGOTINDISULFONATE SODIUM)
PROVEPHARM SAS
0
catalysts
Preclinical
BMD-001
Alzheimer's Disease
Biorchestra Co Ltd
0
catalysts
Phase 1
BMF-650
Obesity
$BMEA
Biomea Fusion, Inc.
0
catalysts
Phase 2
BMND-08
Alzheimer's Disease
Biomind Labs Inc
0
catalysts
Phase 1
BMS-986416
Diffuse Cutaneous Systemic Sclerosis
Bristol-Myers Squibb Co
0
catalysts
Phase 2
BMS-986446
Alzheimer's Disease
Bristol-Myers Squibb Co
0
catalysts
Phase 1
BMS-986497
Myelodysplastic Syndrome (Preleukemia)
Bristol-Myers Squibb Co
0
catalysts
Phase 2
BMX-001
High-Grade Glioma
Biomimetix JV LLC
0
catalysts
Phase 2
BNT-111
Metastatic Melanoma
$BNTX
BioNTech SE
0
catalysts
Phase 3
BNT-113
Recurrent Head And Neck Squamous Cell Carcinoma
$BNTX
BioNTech SE
0
catalysts
Phase 2
BOLD-100
Colorectal Cancer
Bold Therapeutics Inc
0
catalysts
Phase 2
BOXR-1030
Merkel Cell Carcinoma
SOTIO Biotech AS
0
catalysts
Phase 1
BP-1002
Refractory Acute Myeloid Leukemia
$BPTH
BIO-PATH HOLDINGS, INC.
0
catalysts
Preclinical
BP-1003
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$BPTH
BIO-PATH HOLDINGS, INC.
0
catalysts
Preclinical
BP-2202
Multiple Myeloma (Kahler Disease)
BrightPath Biotherapeutics Co Ltd
0
catalysts
Preclinical
BPA
Glioblastoma Multiforme (GBM)
TAE Life Sciences LLC
0
catalysts
